Cohort reports full-year earnings beat on export demand

Cohort reported full-year adjusted EPS of £0.62, beating the £0.60 analyst consensus, alongside 13% YoY revenue growth. Pretax profit was £32.60m, slightly below the £34.51m consensus, but the company raised its dividend per share by 10% and said its record order book supports ~£264m of revenue for 2026/27 (88% coverage). Management targets double-digit earnings growth for 2026/27 through the next two years and expects operating margin to improve to the low-teens in 2026/27.

Analysis

The main positive is not the headline earnings beat; it is the mix shift toward higher-quality defense electronics and secure communications, where pricing power, renewal cycles, and aftermarket-like revenue are better than in legacy project work. That matters because the market typically rewards visibility more than raw growth in this segment, especially when capital returns are being increased and the balance sheet is not the constraint.

The issue is that the profit miss signals operating leverage is still fragile. Weakness in lower-margin legacy programs tells us the next 2-3 quarters matter more than the backlog headline: if execution on mix or conversion slips, the stock can quickly re-rate from “compounder” back to “good industrial.” The real second-order winner is likely the ecosystem around NATO secure comms and C4ISR spending; the loser is any competitor still relying on heavier, lower-margin hardware exposure.

Contrarian view: consensus may be overpaying for backlog visibility. In small-cap defense, backlog quality and cash conversion usually matter more than size, and a large book can still mask program-level volatility. The thesis is falsified if FY26/27 margin progression stalls, export demand rolls over, or forward EPS estimates do not continue to step up over the next reporting cycle.

Key Decisions for Investors

• Buy CHRT on a 3-5% post-print pullback for a 3-6 month trade; target a rerating on margin-upgrade expectations, but exit if the next update fails to reaffirm low-teens margin progression.
• Pair trade: long CHRT / short BA. or CHG over 1-3 months to isolate the higher-quality comms/intelligence mix versus broader platform exposure; cover if CHRT underperforms after the next trading statement.
• If liquidity in CHRT is too tight, use QQ. as the cleaner UK defense proxy and rotate out of lower-margin legacy defense names on rallies; this is a more conservative expression of the same thesis.
• Set an alert for the next consensus reset: if 2026/27 EPS does not move up materially after the next results cycle, trim exposure because the market will likely treat the order book as fully priced.
• Avoid chasing via options unless you confirm tight spreads and open interest; the signal is fundamental, not event-driven enough to justify paying up for convexity.